1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Stimulants 1.2.3 Non-stimulants 1.3 Market by Application 1.3.1 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pediatric and Adolescents 1.3.3 Adults 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Perspective (2016-2027) 2.2 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Growth Trends by Regions 2.2.1 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Industry Dynamic 2.3.1 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Trends 2.3.2 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Drivers 2.3.3 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Challenges 2.3.4 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Players by Revenue 3.1.1 Global Top Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue 3.4 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Concentration Ratio 3.4.1 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue in 2020 3.5 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Key Players Head office and Area Served 3.6 Key Players Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Solution and Service 3.7 Date of Enter into Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Breakdown Data by Type 4.1 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecasted Market Size by Type (2022-2027) 5 Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Breakdown Data by Application 5.1 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2016-2027) 6.2 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type 6.2.1 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2027) 6.3 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application 6.3.1 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2027) 6.4 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country 6.4.1 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2016-2027) 7.2 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type 7.2.1 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2027) 7.3 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application 7.3.1 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2027) 7.4 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country 7.4.1 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type 8.2.1 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application 8.3.1 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Region 8.4.1 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2016-2027) 9.2 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type 9.2.1 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application 9.3.1 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country 9.4.1 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type 10.2.1 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application 10.3.1 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country 10.4.1 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.1.4 Pfizer Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 GSK 11.2.1 GSK Company Details 11.2.2 GSK Business Overview 11.2.3 GSK Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.2.4 GSK Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.2.5 GSK Recent Development 11.3 Eli Lilly 11.3.1 Eli Lilly Company Details 11.3.2 Eli Lilly Business Overview 11.3.3 Eli Lilly Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.3.4 Eli Lilly Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.3.5 Eli Lilly Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.4.4 Novartis Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.5.4 Johnson & Johnson Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Mallinckrodt 11.6.1 Mallinckrodt Company Details 11.6.2 Mallinckrodt Business Overview 11.6.3 Mallinckrodt Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.6.4 Mallinckrodt Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.6.5 Mallinckrodt Recent Development 11.7 Hisamitsu 11.7.1 Hisamitsu Company Details 11.7.2 Hisamitsu Business Overview 11.7.3 Hisamitsu Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.7.4 Hisamitsu Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.7.5 Hisamitsu Recent Development 11.8 UCB 11.8.1 UCB Company Details 11.8.2 UCB Business Overview 11.8.3 UCB Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.8.4 UCB Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.8.5 UCB Recent Development 11.9 Takeda 11.9.1 Takeda Company Details 11.9.2 Takeda Business Overview 11.9.3 Takeda Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.9.4 Takeda Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.9.5 Takeda Recent Development 11.10 Purdue Pharma 11.10.1 Purdue Pharma Company Details 11.10.2 Purdue Pharma Business Overview 11.10.3 Purdue Pharma Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.10.4 Purdue Pharma Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.10.5 Purdue Pharma Recent Development 11.11 Impax Laboratories 11.11.1 Impax Laboratories Company Details 11.11.2 Impax Laboratories Business Overview 11.11.3 Impax Laboratories Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction 11.11.4 Impax Laboratories Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) 11.11.5 Impax Laboratories Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Stimulants Table 3. Key Players of Non-stimulants Table 4. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Regions (2016-2021) Table 8. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Regions (2022-2027) Table 10. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Trends Table 11. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Drivers Table 12. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Challenges Table 13. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Restraints Table 14. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Players (2016-2021) Table 16. Global Top Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics as of 2020) Table 17. Ranking of Global Top Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Solution and Service Table 21. Date of Enter into Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 24. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Type (2016-2021) Table 25. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Application (2016-2021) Table 29. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 32. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 34. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 61. Pfizer Company Details Table 62. Pfizer Business Overview Table 63. Pfizer Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Table 64. Pfizer Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 65. Pfizer Recent Development Table 66. GSK Company Details Table 67. GSK Business Overview Table 68. GSK Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Table 69. GSK Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 70. GSK Recent Development Table 71. Eli Lilly Company Details Table 72. Eli Lilly Business Overview Table 73. Eli Lilly Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Table 74. Eli Lilly Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 75. Eli Lilly Recent Development Table 76. Novartis Company Details Table 77. Novartis Business Overview Table 78. Novartis Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Table 79. Novartis Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 80. Novartis Recent Development Table 81. Johnson & Johnson Company Details Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Table 84. Johnson & Johnson Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 85. Johnson & Johnson Recent Development Table 86. Mallinckrodt Company Details Table 87. Mallinckrodt Business Overview Table 88. Mallinckrodt Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Table 89. Mallinckrodt Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 90. Mallinckrodt Recent Development Table 91. Hisamitsu Company Details Table 92. Hisamitsu Business Overview Table 93. Hisamitsu Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Table 94. Hisamitsu Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 95. Hisamitsu Recent Development Table 96. UCB Company Details Table 97. UCB Business Overview Table 98. UCB Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 99. UCB Recent Development Table 100. Takeda Company Details Table 101. Takeda Business Overview Table 102. Takeda Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Table 103. Takeda Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 104. Takeda Recent Development Table 105. Purdue Pharma Company Details Table 106. Purdue Pharma Business Overview Table 107. Purdue Pharma Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Table 108. Purdue Pharma Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 109. Purdue Pharma Recent Development Table 110. Impax Laboratories Company Details Table 111. Impax Laboratories Business Overview Table 112. Impax Laboratories Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Product Table 113. Impax Laboratories Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) & (US$ Million) Table 114. Impax Laboratories Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Stimulants Features Figure 3. Non-stimulants Features Figure 4. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application: 2020 VS 2027 Figure 5. Pediatric and Adolescents Case Studies Figure 6. Adults Case Studies Figure 7. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Report Years Considered Figure 8. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 9. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Regions: 2020 VS 2027 Figure 11. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Regions (2022-2027) Figure 12. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Players in 2020 Figure 13. Global Top Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics as of 2020 Figure 14. The Top 10 and 5 Players Market Share by Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue in 2020 Figure 15. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Type (2016-2021) Figure 16. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Type (2022-2027) Figure 17. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 18. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2016-2027) Figure 19. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2016-2027) Figure 20. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Country (2016-2027) Figure 21. United States Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. Canada Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2016-2027) Figure 25. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2016-2027) Figure 26. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Country (2016-2027) Figure 27. Germany Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. France Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. U.K. Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Italy Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Russia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Nordic Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2016-2027) Figure 35. Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2016-2027) Figure 36. Asia-Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Region (2016-2027) Figure 37. China Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Japan Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. South Korea Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Southeast Asia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. India Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Australia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2016-2027) Figure 45. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2016-2027) Figure 46. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Country (2016-2027) Figure 47. Mexico Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Brazil Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type (2016-2027) Figure 51. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application (2016-2027) Figure 52. Middle East & Africa Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Country (2016-2027) Figure 53. Turkey Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Saudi Arabia Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. UAE Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Pfizer Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 57. GSK Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 58. Eli Lilly Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 59. Novartis Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 60. Johnson & Johnson Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 61. Mallinckrodt Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 62. Hisamitsu Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 63. UCB Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 64. Takeda Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 65. Purdue Pharma Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 66. Impax Laboratories Revenue Growth Rate in Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Pfizer GSK Eli Lilly Novartis Johnson & Johnson Mallinckrodt Hisamitsu UCB Takeda Purdue Pharma Impax Laboratories